Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2024
4 years of board service in total across 2 boards, counting each seat separately. Longest: Zymeworks Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Foghorn Therapeutics Inc. June 17, 202599.9%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 10, 2025 | Syndax Pharmaceuticals Inc. | Open-market sale | −4,618 | $15.50 | $71,579 |
| Feb 5, 2025 | Syndax Pharmaceuticals Inc. | Grant or award | +18,500 | — | — |
| Feb 5, 2025 | Syndax Pharmaceuticals Inc. | Grant or award | +23,400 | — | — |
Questions about Neil Gallagher
What boards is Neil Gallagher on?
Neil Gallagher sits on the boards of Foghorn Therapeutics Inc. and Zymeworks Inc.
How long has Neil Gallagher served on boards?
Our records show at least 4 years of board service across 2 boards, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.